How A Complex Personalized Medicine Trial Migrated RTSM Software Without Disruption

Standard supply chain logic often fails when every patient receives a custom-manufactured therapy. In these complex scenarios, the conventional model of distributing pre-manufactured inventory to sites is replaced by a high-stakes, just-in-time supply chain. This case study examines a global Phase I oncology trial that outgrew its original provider, requiring a mid-study migration to a system capable of coordinating manufacturing, distribution, and clinical schedules in real time.

The insights focus on bridging the communication gap between clinical and manufacturing supply chains. By integrating directly into an ecosystem of EDC, scheduling, and diagnostics, the trial achieved live visibility into where each participant’s therapy was in the process. This transparency is essential; in personalized medicine, losing track of a treatment timeline can mean losing the participant. The narrative details how to migrate "in-flight" supply records and participant data without creating gaps in the system of record or disrupting site-level operations. For teams navigating advanced therapeutics, this exploration reveals how a reusable operational foundation can reduce setup time and maintain consistency across an entire clinical program.